FEMY
FEMY
NASDAQ · Health Care

Femasys Inc

$2.29
+0.00 (+0.00%)
As of Aug 15, 2:29 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.50M
Net Income
-28,444,308
Gross Margin
62.0%
Profit Margin
-812.3%
Rev Growth
+23.8%
D/E Ratio
0.54
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.0% 62.0% 40.5% 40.5%
Operating Margin -767.0% -690.3% 15.3% 17.8%
Profit Margin -812.3% -771.7% 10.7% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.50M 2.83M 15.13M 13.23M
Gross Profit 2.17M 1.75M 6.13M 5.36M
Operating Income -26,857,044 -19,532,395 2.32M 2.35M
Net Income -28,444,308 -20,686,769 1.62M 1.76M
Gross Margin 62.0% 62.0% 40.5% 40.5%
Operating Margin -767.0% -690.3% 15.3% 17.8%
Profit Margin -812.3% -771.7% 10.7% 13.3%
Rev Growth +23.8% +23.8% -2.3% +23.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.21M 1.21M 1.56M 1.37M
Total Equity 2.24M 2.24M 10.41M 9.80M
D/E Ratio 0.54 0.54 0.15 0.14
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -26,335,164 -20,216,893 3.07M 2.96M
Free Cash Flow 2.53M 2.28M